These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30597989)

  • 1. A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation.
    Tsai HI; Lo CJ; Zheng CW; Lee CW; Lee WC; Lin JR; Shiao MS; Cheng ML; Yu HP
    J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30597989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.
    Tsai HI; Lo CJ; Lee CW; Lin JR; Lee WC; Ho HY; Tsai CY; Cheng ML; Yu HP
    Am J Transl Res; 2021; 13(1):372-382. PubMed ID: 33527031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Allograft Dysfunction After Live Donor Liver Transplantation: It's Time to Redefine?
    Pamecha V; Pattnaik B; Sinha PK; Patil NS; Sasturkar SV; Mohapatra N; Kumar G; Choudhury A; Sarin SK
    J Clin Exp Hepatol; 2022; 12(1):101-109. PubMed ID: 35068790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction.
    Cortes M; Pareja E; García-Cañaveras JC; Donato MT; Montero S; Mir J; Castell JV; Lahoz A
    J Hepatol; 2014 Sep; 61(3):564-74. PubMed ID: 24798621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Pomposelli JJ; Goodrich NP; Emond JC; Humar A; Baker TB; Grant DR; Fisher RA; Roberts JP; Olthoff KM; Gillespie BW; Merion RM
    Transplantation; 2016 Jul; 100(7):1490-9. PubMed ID: 27326811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Role of Intraoperative Serum Brain Natriuretic Peptide for Early Allograft Dysfunction in Living Donor Liver Transplantation.
    Chae MS; Koo JM; Park CS
    Ann Transplant; 2016 Aug; 21():538-49. PubMed ID: 27572618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio is a predictor of early graft dysfunction following living donor liver transplantation.
    Kwon HM; Moon YJ; Jung KW; Park YS; Jun IG; Kim SO; Song JG; Hwang GS
    Liver Int; 2019 Aug; 39(8):1545-1556. PubMed ID: 30903725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor to protein C ratio-related thrombogenicity with systemic inflammation is predictive of graft dysfunction after liver transplantation: Retrospective cohort study.
    Kwon HM; Kim KS; Park J; Jeong J; Moon YJ; Song JG; Hwang GS; Kim KH; Jun IG
    Int J Surg; 2020 Dec; 84():109-116. PubMed ID: 33137460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction model for early graft failure after liver transplantation using aspartate aminotransferase, total bilirubin and coagulation factor.
    Rhu J; Kim JM; Kim K; Yoo H; Choi GS; Joh JW
    Sci Rep; 2021 Jun; 11(1):12909. PubMed ID: 34145352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft Regeneration and Functional Recovery in Patients with Early Allograft Dysfunction After Living-Donor Liver Transplantation.
    Chae MS; Kim Y; Lee N; Chung HS; Park CS; Lee J; Choi JH; Hong S
    Ann Transplant; 2018 Jul; 23():481-490. PubMed ID: 30013021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Yang L; Xin EY; Liao B; Lai LJ; Han M; Wang XP; Ju WQ; Wang DP; Guo ZY; He XS
    Transplant Proc; 2017; 49(6):1357-1363. PubMed ID: 28736007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of early allograft dysfunction using serum phosphorus level in living donor liver transplantation.
    Hong SH; Kwak JA; Chon JY; Park CS
    Transpl Int; 2013 Apr; 26(4):402-10. PubMed ID: 23350888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive utility of the C-reactive protein to albumin ratio in early allograft dysfunction in living donor liver transplantation: A retrospective observational cohort study.
    Park J; Lim SJ; Choi HJ; Hong SH; Park CS; Choi JH; Chae MS
    PLoS One; 2019; 14(12):e0226369. PubMed ID: 31821367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of real-time metabolomics in liver transplantation: Graft evaluation and donor-recipient matching.
    Faitot F; Besch C; Battini S; Ruhland E; Onea M; Addeo P; Woehl-Jaeglé ML; Ellero B; Bachellier P; Namer IJ
    J Hepatol; 2018 Apr; 68(4):699-706. PubMed ID: 29191459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Deschênes M; Belle SH; Krom RA; Zetterman RK; Lake JR
    Transplantation; 1998 Aug; 66(3):302-10. PubMed ID: 9721797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric Acid as a Predictor for Early Allograft Dysfunction after Living Donor Liver Transplantation: A Prospective Observational Study.
    Hu LM; Tsai HI; Lee CW; Chen HM; Lee WC; Yu HP
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34205627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-GrAFT
    Li S; Luo Q; Chen S; Jia Z; Wang T; Yu X; Wang W; YuyiZhang ; Zhu J; Deng F; Sun Q; Guo Z; He X
    J Clin Transl Hepatol; 2024 Jan; 12(1):62-69. PubMed ID: 38250465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
    Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.